Screen. Test. Treat.

Diabetes Testing Centers™ (DTC) has evolved beyond diabetes-related risk detection into a broader chronic-risk testing platform for modern primary care. Designed to integrate inside existing PCP clinics using as little as one dedicated room, DTC helps practices add structured pre-screening, focused testing, and assessment pathways without building a separate clinic, disrupting daily operations, or requiring major space expansion.

The DTC model is simple: screen earlier, test when risk signals are present, and help providers guide patients toward timely treatment, monitoring, or appropriate follow-up care before silent risks become serious complications.

DTC was built for primary care organizations to help providers detect hidden risk signals earlier, support medical-necessity documentation, and connect those signals to non-invasive, billable point-of-care testing pathways. Using TriageIQ™ as the intake-level pre-screener, providers can identify where risk may exist, then determine which focused screeners, assessments, diagnostics, or follow-up pathways may be clinically appropriate during the same visit or through remote/mobile testing options.

DTC was founded by former family practice owners who saw firsthand how often chronic risks are missed until patients have already begun suffering preventable damage. That experience, combined with enterprise healthcare leadership in diagnostics and diabetes, shaped DTC’s development of scalable, non-invasive, billable programs for modern primary care. Today, with access to a national network of more than 20,000 independent practices, DTC helps providers bring earlier detection, focused testing, and appropriate care direction into the clinical workflow they already use.

Most chronic diseases do not begin with a diagnosis. They often begin years earlier with subtle changes in how a patient feels, functions, moves, sees, thinks, or tolerates daily life—changes that may not appear in routine labs and may never become documented concerns. Patients often notice these changes but explain them away as aging, stress, fatigue, or “just getting older.” They may not schedule a separate visit, mention them during an existing visit, or follow up until symptoms become impossible to ignore. By then, the underlying disease process may have been active for years.

This is the gap DTC is designed to close—not by adding complexity, but by building a practical 'Screen. Test. Treat.' pathway into the front end of care. No extra appointment. No separate clinic. No waiting for the patient to decide a symptom is worth reporting. By capturing patient-reported risk signals at intake, documenting them while the patient is already present, and connecting them to focused testing when appropriate, DTC helps providers create a clearer path from early risk recognition to clinical action. The visit does not change, only the clinical intelligence it produces does.

Find Hidden Risks

In-Clinic or At-Home

The earliest risk signals often begin where the patient is — through symptoms, functional changes, and subtle clinical patterns that may appear before they’re formally documented in the chart. That’s why TriageIQ™ is designed to support intake both in-clinic and at-home, giving providers a more consistent way to capture patient-reported risk signals before the visit, during intake, or as part of remote outreach.

Adults represent the largest immediately addressable clinical population and carry the greatest overall burden of chronic disease risk. This matters because many chronic conditions become more common, measurable, and clinically actionable during adulthood. TriageIQ™ Adult helps pre-screen patients for early risk signals across five core clinical domains, giving providers a broader intake picture before deciding whether focused single-domain screeners, assessments, testing, or additional diagnostic pathways may be appropriate.

1. 👥 Population Health: A broad baseline view of patient risk and care-navigation needs. 

2. ❤️ Cardiometabolic: Related to metabolic, vascular, and cardiovascular risk direction. 

3. 🧠 Neurological: Supports early recognition of brain, nerve, balance, and functional-risk patterns. 

4. 🧩 Behavioral: Helps surface behavioral, emotional, sleep, and whole-person risk signals. 

5. 🚶 Pain & Function: Related to pain burden, movement, daily activity, and physical function. 

TriageIQ™ is a proprietary 3-minute adult multi-domain pre-screener that helps identify potential risk signals across five clinical domains and supports provider review for medically necessary follow-up.  

Detecting these risks earlier helps protect patients before complications become life-altering. DTC supports the clinical strategy behind Chronic Risk Assessments used by providers nationwide, with flexible in-clinic and at-home workflows designed to improve access, strengthen documentation, and create a scalable pathway for earlier identification, appropriate follow-up, and recurring clinical value. 

Turn Intake to Insight

find what others miss

The clinical case for earlier testing is not theoretical—it is measurable, documentable, and supported by written patient-reported risk signals captured at intake. By converting what patients may already be experiencing into structured documentation before the provider encounter, practices may better support the clinical rationale and medical necessity for appropriate follow-up testing, assessment, monitoring, or care planning.

Chronic risks often begin silently. Damage may accumulate long before symptoms become obvious, leaving providers to intervene later when care becomes more reactive, costly, and complex. The challenge is that most primary care workflows are not built to consistently capture risk during that earlier window. Patients present with a chief complaint. Providers respond to what is reported. But what is not reported — early nerve changes, subtle cognitive shifts, vascular risk signals, behavioral health burden, or functional decline — may be missed when intake is not structured to pre-screen across multiple domains and guide appropriate follow-up testing.

DTC exists to help practices find what others miss and act on those signals through earlier, more accessible testing. With in-clinic and remote testing options, DTC helps providers evaluate risk from wherever the patient is located — inside the practice, at home, in the workplace, or through mobile outreach when needed. By connecting structured pre-screening with focused in-clinic or remote testing, DTC helps providers identify risk earlier, support medical-necessity documentation, and guide patients toward appropriate next steps before silent risks become serious complications.

The providers who benefit most are not adding complexity. They’re unlocking clinical value already present in their existing patient panel and visit flow by using a structured pathway to surface risk earlier, document it clearly, and move patients toward timely care.

Test Everywhere